Image for representational purposes only. | Photo Credit: The Hindu Bharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at ₹800 (excluding GST) for private markets and ₹325 (excluding GST) for government supplies. A press release from the vaccine maker said the jab … Read more
COVID-19 vaccine Covaxin maker Bharat Biotech said there was no external pressure on the firm to speed up its development. Photo: Special Arrangement The Union Health Ministry on November 17 termed as “misleading” and “fallacious” media reports which claimed that regulatory approval for COVID-19 vaccine Covaxin was rushed due to political pressure. It said scientific … Read more
The NTAGI’s Standing Technical Sub-Committee (STSC) approved the use of COVID-19 vaccines Corbevax and Covaxin for children aged between five and 12 years, official sources said on Friday. However, there was no decision on introducing these vaccines in the vaccination programme. Data of Biological E’s Corbevax and Bharat Biotech’s Covaxin for children aged between five … Read more
Bharat Biotech’s Covid-19 vaccine — Covaxin — has reported higher neutralising antibodies in children and on an average, it was 1.7 times higher than in adults. The vaccine was well-tolerated and immunogenic in paediatric subjects in Phase II/III study. The study has been accepted and published in Lancet Infectious Diseases. Covaxin is one of the … Read more
Bharat Biotech International Ltd on Friday said its COVID-19 vaccine Covaxin has proven to be safe, well-tolerated and highly immunogenic in children and adolescents of 2-18 years age group in phase II/III study. The company conducted phase II/III, open-label, and multicentre study to evaluate the safety, reactogenicity and immunogenicity of Covaxin in healthy children and … Read more
Government advisory panel NTAGI will meet on Thursday to review data on Covaxin and Corbevax vaccines for the 6-12 age group and also deliberate on reducing the gap between the second and precaution doses from the current nine to six months. The National Technical Advisory Group on Immunisation (NTAGI) will hold its meeting amid a … Read more
German Ambassador to India and Bhutan, Walter J Lindner on Thursday said the government of the European nation will start recognizing Bharat Biotech’s COVID-19 vaccine for travel purpose there from June 1. In a tweet, Lindner said, “Very happy that GER government just decided to recognize WHO-listed Covaxin for travels to GER, starting June 1! … Read more
The US Food and Drug Administration which has put on hold the phase 2/ 3 clinical trials of Bharat Biotech’s COVID-19 vaccine Covaxin, in USA, has lifted the pause, according to a statement issued by Ocugen Inc, Bharat Biotech’s partner for the jab in USA and Canada. “We’re extremely pleased that we can proceed with … Read more
Rejecting the allegations of non-disclosure of segregated clinical data and haste in granting approval to Covaxin and Covishield, the two main Covid vaccines approved by the government, the SC said the results of Phase III clinical trials of these vaccines have been published, in line with the requirement under the statutory regime in place, the … Read more
The Drugs Controller General of India (DCGI) granted emergency use authorisation for Biological E’s Covid-19 vaccine Corbevax for children aged five to 12 years, and Bharat Biotech’s Covaxin for children in the age group of six to 12 years, on Tuesday. The DCGI has also granted emergency use authorisation (EUA) to Cadila for its ZyCoV-D … Read more